Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001396814-25-000061
Filing Date
2025-05-08
Accepted
2025-05-08 16:07:07
Documents
104
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q - PCRX - 3.31.2025 pcrx-20250331.htm   iXBRL 10-Q 1435458
2 EX-10.1 pcrx-ex101x3x312025.htm EX-10.1 147579
3 EX-31.1 pcrx-3312025xex311.htm EX-31.1 11793
4 EX-31.2 pcrx-3312025xex312.htm EX-31.2 11768
5 EX-32.1 pcrx-3312025xex321.htm EX-32.1 8199
11 PACIRA BIOSCIENCES LOGO pcrx-20250331_g1.jpg GRAPHIC 82257
12 PRODUCT PIPELINE pcrx-20250331_g2.jpg GRAPHIC 304796
  Complete submission text file 0001396814-25-000061.txt   10899104

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT pcrx-20250331.xsd EX-101.SCH 66672
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT pcrx-20250331_cal.xml EX-101.CAL 99078
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT pcrx-20250331_def.xml EX-101.DEF 478459
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT pcrx-20250331_lab.xml EX-101.LAB 879603
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT pcrx-20250331_pre.xml EX-101.PRE 671119
107 EXTRACTED XBRL INSTANCE DOCUMENT pcrx-20250331_htm.xml XML 1393960
Mailing Address 2000 SIERRA POINT PARKWAY SUITE 900 BRISBANE CA 94005
Business Address 2000 SIERRA POINT PARKWAY SUITE 900 BRISBANE CA 94005 650-242-8052
Pacira BioSciences, Inc. (Filer) CIK: 0001396814 (see all company filings)

EIN.: 510619477 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35060 | Film No.: 25926009
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)